We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stratasys (SSYS) Launches Digital Anatomy Creator Software
Read MoreHide Full Article
Stratasys (SSYS - Free Report) recently announced the launch of a new software module — Digital Anatomy Creator — designed for its Digital Anatomy 3D Printers to enhance personalized healthcare through anatomic modeling solutions.
The software enables healthcare providers to easily manipulate material formations and customize their prints’ eternal structures for patient-specific anatomic models, which are a replication of the patient’s pathologic and biologic anatomy.
With the Digital Anatomy Creator, the users will be able to create, explore and share ultra-realistic designs of patient-specific anatomies across communities. They will be able to access additional options and controls to calibrate printing materials, thus fulfilling user-specific, personalised, anatomic model requirements.
Stratasys collaborated with Synopsys’ (SNPS - Free Report) Simpleware ScanIP Medical and Materialise’s (MTLS - Free Report) Mimics inPrint to certify its Digital Anatomy and J5 MediJet printers to be included in FDA 510(k) cleared medical modeling workflows. This will give customers access to digital workflows for diagnostic anatomic modeling and enhance point-of-care 3D printing.
Of late, Stratasys has been expanding its materials ecosystem across P3, Selective Absorption Fusion (“SAF”), and stereolithography 3D printing systems. Recently, in November, it launched an Open Material License to advance its manufacturing strategy with a new open tier of third-party materials for FDM 3D printers. This enabled its manufacturing customers to address new applications with demanding requirements, while having dual material sources.
In October, Stratasys introduced GrabCAD Additive Manufacturing Platform, an open and enterprise-ready software platform that enables manufacturers to manage production-scale additive manufacturing operations.
In September, the company introduced an Open Material License for the P3-based Origin One along with two new materials from Loctite by Henkel. Earlier, in June, it expanded its software ecosystem with the addition of Teton Simulation, which utilizes GrabCAD DFAM Software Development Kit to help customers improve the reliability of additive manufacturing builds.
Stratasys and Synonpsys currently carry a Zacks Rank #3 (Hold), while Materialise sports a Zacks Rank #1 (Strong Buy). Shares of SSYS and SNPS have appreciated 30.4% and 37.3%, respectively, while MTLS has depreciated 56.1% in the year-to-date (“YTD”) period.
The Zacks Consensus Estimate for Advanced Micro Devices’ fourth-quarter 2021 earnings has been revised upward by 8 cents to 76 cents per share over the past 60 days. For 2021, earnings estimates moved north by 15 cents to $2.65 per share in the last 60 days.
Advanced Micro Devices’ earnings beat the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 14%. Shares of AMD have rallied 76.5% in the YTD period.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
Stratasys (SSYS) Launches Digital Anatomy Creator Software
Stratasys (SSYS - Free Report) recently announced the launch of a new software module — Digital Anatomy Creator — designed for its Digital Anatomy 3D Printers to enhance personalized healthcare through anatomic modeling solutions.
The software enables healthcare providers to easily manipulate material formations and customize their prints’ eternal structures for patient-specific anatomic models, which are a replication of the patient’s pathologic and biologic anatomy.
With the Digital Anatomy Creator, the users will be able to create, explore and share ultra-realistic designs of patient-specific anatomies across communities. They will be able to access additional options and controls to calibrate printing materials, thus fulfilling user-specific, personalised, anatomic model requirements.
Stratasys collaborated with Synopsys’ (SNPS - Free Report) Simpleware ScanIP Medical and Materialise’s (MTLS - Free Report) Mimics inPrint to certify its Digital Anatomy and J5 MediJet printers to be included in FDA 510(k) cleared medical modeling workflows. This will give customers access to digital workflows for diagnostic anatomic modeling and enhance point-of-care 3D printing.
Of late, Stratasys has been expanding its materials ecosystem across P3, Selective Absorption Fusion (“SAF”), and stereolithography 3D printing systems. Recently, in November, it launched an Open Material License to advance its manufacturing strategy with a new open tier of third-party materials for FDM 3D printers. This enabled its manufacturing customers to address new applications with demanding requirements, while having dual material sources.
In October, Stratasys introduced GrabCAD Additive Manufacturing Platform, an open and enterprise-ready software platform that enables manufacturers to manage production-scale additive manufacturing operations.
In September, the company introduced an Open Material License for the P3-based Origin One along with two new materials from Loctite by Henkel. Earlier, in June, it expanded its software ecosystem with the addition of Teton Simulation, which utilizes GrabCAD DFAM Software Development Kit to help customers improve the reliability of additive manufacturing builds.
Stratasys, Ltd. Price and Consensus
Stratasys, Ltd. price-consensus-chart | Stratasys, Ltd. Quote
Zacks Rank & Stocks to Consider
Stratasys and Synonpsys currently carry a Zacks Rank #3 (Hold), while Materialise sports a Zacks Rank #1 (Strong Buy). Shares of SSYS and SNPS have appreciated 30.4% and 37.3%, respectively, while MTLS has depreciated 56.1% in the year-to-date (“YTD”) period.
A better-ranked stock in the broader technology sector includes Advanced Micro Devices (AMD - Free Report) , which carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Advanced Micro Devices’ fourth-quarter 2021 earnings has been revised upward by 8 cents to 76 cents per share over the past 60 days. For 2021, earnings estimates moved north by 15 cents to $2.65 per share in the last 60 days.
Advanced Micro Devices’ earnings beat the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 14%. Shares of AMD have rallied 76.5% in the YTD period.